Categories
Articles

Construction and Growth Properties of Recombinant Pseudorabies Virus Expressing Modified Enhanced Green Fluorescent Protein

Construction and Growth Properties of Recombinant Pseudorabies Virus Expressing Modified Enhanced Green Fluorescent Protein


FANG Liu-Rong, CHEN Huan-Chun, XIAO Shao-Bo, ZHANG Hui, NIU Chuan-Shuang

( Laboratory of
Animal Virology, College of Animal Science and Veterinary Medicine, Huazhong
Agricultural University, Wuhan 430070, China )

Abstract

The
1.0 kb DNA fragment containing the modified enhanced green fluorescent protein
CDNA M1 (EGFP S147/P) and SV40 poly(A) signal seque nce w as
amplified and cloned in frame behind the first eight codons of the nonessential
glycoprotein G (gG) of pseudorabies virus (PRV) to yield a transfer plasmid.
The transfer plasmid was linearized and cotransfected with the genomic DNA
of P RV Ea mutant gG/LacZ+. The resulting recombinant
virus expressing M1, desig n ated as gG/LacZ+, was
isolated and confirmed by plaque purification, PCR, So uthern blot and Western
blot. PK-15 cells were infected with the purified recom binant virus at 0.1
pfu/cell and fluorescence emission was monitored at differen t times post-infection
(p.i.) using fluorescence microscopy. Fluorescence emiss ion could be detected
as early as 6 h p.i. when there was no apparent cytopathic effects (CPE) yet.
Fluorescence intensity increased drastically later. Maximu m intensity was
achieved at 24-36 h p.i. and fluorescence was stable. With the progress of
the CPE, fluorescence vanished. The growth properties of gG/M1+
in tissue cultures were further examined and the titer of gG/M1+
was similar to that of PRV Ea wild strain and the parental strain gG/LacZ+.
The abov e results indicated that the recombinant virus expressing the modified
EGFP can be used as an in vivo marker to monitor replication and spread,
as well as t o study the molecular pathogenesis of PRV.

Key
words
pseudorabies virus (PRV); modified enhanced green fluorescent
protein; marker; growth properties

Corresponding
author:
Tel,
86-27-87282608; e-mail, [email protected]